Canje-canje a cikin Changzhou Pharmaceutical Factory Ltd.wani reshe na Shanghai Pharmaceutical Holdings, ya karɓi Takaddun Rijistar Magunguna (Takaddun shaida No. 2021S01077, 2021S01078, 2021S01079) wanda Hukumar Kula da Magunguna ta Jiha ta bayar donLenalidomide capsules(Takaddun shaida 5mg, 10mg, 25mg), wanda aka yarda don samarwa.
Bayanan asali
Sunan magani:Lenalidomide capsules
Sigar sashi:Capsule
Ƙayyadaddun bayanai:5mg, 10mg, 25mg
Rarraba rajista:Magungunan sinadarai 4
Lambar tsari:Takaddun Magani na Jiha H20213802, Takaddun Magungunan Jiha H20213803, Takaddun Magungunan Jiha H20213804
Ƙarshen Amincewa: Haɗu da buƙatun rajista na miyagun ƙwayoyi, an yarda don rajista, bayar da takardar shaidar rajistar miyagun ƙwayoyi.
Bayani mai alaƙa
Lenalidomidewani sabon ƙarni ne na maganin rigakafi na baka tare da aikin hana haɓakar ƙwayar ƙwayar cuta, haifar da apoptosis cell tumor da immunomodulation, wanda aka fi amfani dashi a cikin maganin myeloma da yawa da ciwo na myelodysplastic (MDS) da sauran yanayi.Ana amfani da shi tare da dexamethasone don kula da manya marasa lafiya tare da myeloma da yawa da ba a yi musu magani a baya ba waɗanda ba 'yan takarar dasawa ba.Ana amfani da wannan samfurin a hade tare da dexamethasone don kula da manya marasa lafiya tare da myeloma da yawa waɗanda suka sami aƙalla magani ɗaya kafin.Ana amfani da wannan samfurin a haɗe tare da rituximab don kula da manya marasa lafiya tare da lymphoma follicular (maki 1-3a) waɗanda suka karɓi maganin farko.
Lenalidomide capsules an fara kera su ne ta hanyar Celgene Biopharmaceuticals kuma an sayar da su a cikin Amurka a cikin 2005. a cikin Disamba 2019, masana'antar harhada magunguna ta Changzhou ta shigar da takardar rajista da tallace-tallace ga Hukumar Kula da Magunguna ta Jiha don maganin, wanda aka karɓa.
Bayanai daga Minene.com sun nuna cewa tallace-tallace na kasa na Nalidomide capsules a cikin 2020 zai kai kusan RMB biliyan 1.025.
Dangane da manufofin kasa da suka dace, nau'ikan magungunan da aka amince da su bisa ga sabon rabe-raben rajista za su sami babban tallafi a fannoni kamar biyan inshorar likita da sayan cibiyoyin likita.Saboda haka, da yarda samar daKamfanin Magunguna na Changzhou's lenalidomidecapsule yana da amfani don ƙara faɗaɗa kason sa na kasuwa a fannin maganin ciwon jini-tumor da haɓaka ƙwaƙƙwaran kasuwa, da kuma tara ƙwarewa mai mahimmanci ga samfuran kamfanin na gaba don aiwatar da haɓakar magunguna da rajista.